Kukje Pharma Co., Ltd. (002720.KS)
KRW 4970.0
(-2.17%)
KRW 4970.0
(-2.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.57 Billion | 6.5 Billion | 9.59 Billion | 5.09 Billion | 3.6 Billion | 13.24 Billion |
| Net Income | -8.41 Billion | 3.54 Billion | -1.55 Billion | 2.19 Billion | -4.76 Billion | 2.18 Billion |
| Depreciation & Amortization | 4.2 Billion | 4.48 Billion | 4.41 Billion | 3.62 Billion | 3.25 Billion | 2.74 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 5.42 Billion | -4.27 Billion | 5.59 Billion | -8.93 Billion | -439.52 Million | 7.12 Billion |
| Other non-cash items | 2.35 Billion | 2.74 Billion | 1.13 Billion | 8.21 Billion | 5.55 Billion | 1.2 Billion |
| Investing Cash Flow | -1.17 Billion | -1.34 Billion | -3.38 Billion | -8.98 Billion | -5.12 Billion | -6.43 Billion |
| Investments in PPE | -1.04 Billion | -1.27 Billion | -1.96 Billion | -11.59 Billion | -5.88 Billion | -3.45 Billion |
| Acquisitions | 35.74 Million | 81.44 Million | -45.13 Million | -2 Billion | 16.63 Million | 1.19 Billion |
| Investment purchases | -50 Million | - | -1.46 Billion | -202 Million | -1.3 Billion | -200 Million |
| Sales/Maturities of investments | 510 Million | - | 100.74 Million | 890.01 Million | 179.1 Million | 1.39 Billion |
| Other Investing Activities | -624.89 Million | -151.54 Million | -14.55 Million | 3.93 Billion | 1.86 Billion | -4.17 Billion |
| Financing Cash Flow | 2.6 Billion | -7.47 Billion | -2.43 Billion | 621.95 Million | 5.33 Billion | -5.68 Billion |
| Debt repayment | -3 Billion | -7 Billion | -2 Billion | -6.41 Billion | -7.22 Billion | -8.9 Billion |
| Dividends payments | - | - | - | - | -515.12 Million | -165.12 Million |
| Common Stock Repurchased | -31.06 Million | -40.61 Million | -45.53 Million | - | -12.22 Million | -17.4 Million |
| Common Stock Issuance | - | - | - | - | 13.08 Billion | - |
| Other Financing Activities | 5.64 Billion | -433.02 Million | -388.35 Million | 7.03 Billion | 330.00 | 3.4 Billion |
| Accounts receivables | 565.75 Million | 4.64 Billion | 4.59 Billion | 4.24 Billion | -1.28 Billion | 5.36 Billion |
| Accounts payables | 11.57 Billion | 711.14 Million | 933.17 Million | -4.7 Billion | 3.83 Billion | -1.52 Billion |
| Inventory | 1.28 Billion | -4.78 Billion | 3.26 Billion | -5.52 Billion | -2.33 Billion | 2.93 Billion |
| Other working capital | -8 Billion | -4.84 Billion | -3.19 Billion | -2.94 Billion | -652.76 Million | 4.18 Billion |
| Cash at beginning of period | 5.53 Billion | 7.86 Billion | 4.01 Billion | 7.44 Billion | 3.65 Billion | 2.52 Billion |
| Cash at end of period | 10.58 Billion | 5.53 Billion | 7.86 Billion | 4.01 Billion | 7.44 Billion | 3.65 Billion |
| Capital Expenditure | -1.04 Billion | -1.27 Billion | -1.96 Billion | -11.59 Billion | -5.88 Billion | -3.45 Billion |
| Effect of forex changes on cash | 40.81 Million | -10.37 Million | 71.65 Million | -176.29 Million | -20.76 Million | -1.78 Million |
| Net cash flow / Change in cash | 5.05 Billion | -2.32 Billion | 3.85 Billion | -3.43 Billion | 3.78 Billion | 1.13 Billion |
| Free Cash Flow | 2.52 Billion | 5.22 Billion | 7.63 Billion | -6.49 Billion | -2.28 Billion | 9.79 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 597.39 Million | 2.74 Billion | -389.14 Million | -8.41 Billion | -2.59 Billion | -6.26 Billion |
| Depreciation & Amortization | 807.52 Million | 814.63 Million | 943.41 Million | 4.2 Billion | 1.06 Billion | 1.09 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -305.26 Million | -2.19 Billion | -1.13 Billion | 5.42 Billion | 929.65 Million | 4.25 Billion |
| Other non-cash items | -3.01 Billion | 7.45 Billion | 1.18 Billion | 2.35 Billion | -450.53 Million | 1.64 Billion |
| Investing Cash Flow | -974.29 Million | -191.99 Million | -71.19 Million | -1.17 Billion | -969.91 Million | 199.95 Million |
| Investments in PPE | -1.18 Billion | -247.67 Million | -186.62 Million | -1.04 Billion | -228.53 Million | -307.93 Million |
| Acquisitions | 54.47 Million | 12.54 Million | 3.79 Million | 35.74 Million | 27.29 Million | 1.35 Million |
| Investment purchases | - | - | - | -50 Million | - | -50 Million |
| Sales/Maturities of investments | 117.91 Million | - | - | 510 Million | - | 510 Million |
| Other Investing Activities | 207.74 Million | 43.12 Million | 111.62 Million | -624.89 Million | -768.67 Million | 46.53 Million |
| Financing Cash Flow | -3.05 Billion | -56.46 Million | -64.71 Million | 2.6 Billion | -86.66 Million | 2.86 Billion |
| Debt repayment | -50.46 Million | - | - | -3 Billion | - | -3 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -31.06 Million | - | -31.06 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3 Billion | - | - | 5.64 Billion | - | 5.89 Billion |
| Accounts receivables | -586.29 Million | 114.3 Million | -932.58 Million | 565.75 Million | 1.99 Billion | -487.83 Million |
| Accounts payables | -2.83 Billion | -4.47 Billion | 4.07 Billion | 11.57 Billion | 1.26 Billion | 4.75 Billion |
| Inventory | 24.47 Million | -459.33 Million | 994.27 Million | 1.28 Billion | -824 Million | 1.09 Billion |
| Other working capital | 256.55 Million | 2.63 Billion | -5.27 Billion | -8 Billion | -1.5 Billion | -1.11 Billion |
| Cash at beginning of period | 12.74 Billion | 10.58 Billion | 10.14 Billion | 5.53 Billion | 12.23 Billion | 8.43 Billion |
| Cash at end of period | 6.82 Billion | 12.74 Billion | 10.58 Billion | 10.58 Billion | 10.14 Billion | 12.23 Billion |
| Capital Expenditure | -1.18 Billion | -247.67 Million | -186.62 Million | -1.04 Billion | -228.53 Million | -307.93 Million |
| Effect of forex changes on cash | 23.53 Million | 30.45 Million | -26.95 Million | 40.81 Million | 10.07 Million | 4.91 Million |
| Net cash flow / Change in cash | -5.91 Billion | 2.15 Billion | 446.88 Million | 5.05 Billion | -2.09 Billion | 3.79 Billion |
| Free Cash Flow | -3.09 Billion | 2.12 Billion | 423.12 Million | 2.52 Billion | -1.27 Billion | 418.96 Million |
4512
N3IA
6002
NEWBRY
688305
VANTI